Michael Witcher
Impact in
- Aging top 5%
-
- Circadian rhythm and melatonin
Papers in
-
- Protein Degradation and Inhibitors 8
- Epigenetics and DNA Methylation 8
- Genomics and Chromatin Dynamics 8
- RNA modifications and cancer 7
- Cancer-related gene regulation 4
- DNA Repair Mechanisms 3
- Ubiquitin and proteasome pathways 3
- Oncology 9
- PARP inhibition in cancer therapy 8
- Co-authors
- Tatiana Shorstova (4 shared papers)Beverly M. Emerson (3 shared papers)William D. Foulkes (4 shared papers)Maud Marques (12 shared papers)Khalid Hilmi (3 shared papers)Tiejun Zhao (9 shared papers)Maïka Jangal (7 shared papers)Hiep D. Le (1 shared paper)
- Journals
- Cancer Research (5 papers)Nucleic Acids Research (3 papers)Blood (2 papers)Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2 papers)PLoS ONE (2 papers)
- Partner nations
- CanadaUnited StatesJapan
In The Last Decade
Michael Witcher
38 papers receiving 1.7k citations
Michael Witcher's Hit Papers
Peers
Comparison fields: 5 of 102
- Aging 56
- Endocrine and Autonomic Systems 130
- Molecular Biology 1.3k
- Cancer Research 155
- Hematology 115
Countries citing papers authored by Michael Witcher
This map shows the geographic impact of Michael Witcher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Witcher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Witcher more than expected).
Fields of papers citing papers by Michael Witcher
This network shows the impact of papers produced by Michael Witcher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Witcher. The network helps show where Michael Witcher may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Witcher, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Achieving clinical success with BET inhibitors as anti-cancer agents Hit paper breakdown → | 2021 | 239 |
| 2 | 2011 | 198 | |
| 3 | 2009 | 194 | |
| 4 | 2016 | 161 | |
| 5 | 2020 | 99 | |
| 6 | 2015 | 81 | |
| 7 | 2018 | 71 | |
| 8 | 2017 | 62 | |
| 9 | 2017 | 60 | |
| 10 | 2003 | 60 | |
| 11 | 2015 | 59 | |
| 12 | 2020 | 55 | |
| 13 | 2019 | 53 | |
| 14 | 2016 | 39 | |
| 15 | 2001 | 31 | |
| 16 | 2018 | 29 | |
| 17 | 2019 | 27 | |
| 18 | 2014 | 26 | |
| 19 | 2016 | 25 | |
| 20 | 2018 | 25 |
About Michael Witcher
Michael Witcher is a scholar working on Molecular Biology, Oncology, Pathology and Forensic Medicine, Hematology and Immunology, having authored 38 papers that have together received 1.7k indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (8 papers), PARP inhibition in cancer therapy (8 papers), Epigenetics and DNA Methylation (8 papers), Genomics and Chromatin Dynamics (8 papers), RNA modifications and cancer (7 papers), Cancer-related gene regulation (4 papers), DNA Repair Mechanisms (3 papers) and Ubiquitin and proteasome pathways (3 papers). The work is most often cited by research in Aging (56 citations), Endocrine and Autonomic Systems (130 citations), Molecular Biology (1.3k citations), Cancer Research (155 citations) and Hematology (115 citations). Michael Witcher has collaborated with scholars based in Canada, United States and Japan. Frequent co-authors include Tatiana Shorstova, Beverly M. Emerson, William D. Foulkes, Maud Marques, Khalid Hilmi, Tiejun Zhao, Maïka Jangal, Hiep D. Le, Satchidananda Panda and Luciano DiTacchio. Their work appears in journals such as Cancer Research, Nucleic Acids Research, Blood, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.